top life sciences private equity firms

Within healthcare, Gemini targets companies in the provider services industry and companies that live in the healthcare sector but do not have direct reimbursement risk . The Riverside Company Founded in 1988 and based out of New York, Riverside considers a wide range of investments in many industries, including healthcare. Based in Boston, the firm pursues a wide range of investments in companies with revenue between $10 million and $50 million and prefers to make more substantial investments from a dollars perspective. Two years later, the firm topped off a second fund at $1.1 billion. Companies in its portfolio include Celerion Holdings, which provides clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research; AGS Health, a revenue cycle management company providing billing and coding services; MDsave, which provides an online location for consumers to research, compare and purchase medical services; and Vital Decisions, a provider of behavioral counseling services to patients with advanced illness. The firm targets companies with revenue up to $100 million, and considers a variety of investments within the lower middle market. Based in Greenwich, Conn., the firm prefers to make more substantial investments from a dollars perspective in companies with EBITDA of $10 million to $75 million. More information about Pharos is available at www.pharosfunds.com. Pamlico also targets companies in business and technology services and communications. Read more about Apple Tree at And within healthcare, biotech appears to be a focus. Current companies in its portfolio include Smile Source, a network of over 350 independent dental practices in the United States. All Rights Reserved. Companies in its portfolio include Braeburn Pharmaceuticals, a developer of solutions for people living with opioid addiction; Stoke Therapeutics, which focuses on gene expression to treat a wide array of diseases caused by genetic insufficiency; and ROX Medical, a late-stage medical device company developing a device treatment of drug resistant hypertension. It considers a broad range of investments in companies in the provider services and non-reimbursement healthcare industries, as well as hospitals and other major facilities. Companies like C4 Therapeutics and Mersana Therapeutics are trying to treat a variety of cancers, from lung to ovarian. With offices in Boston and San Francisco, this firm invests in healthcare services, business and IT services, and high-value manufacturing. Companies in its healthcare portfolio include LabConnect, a provider of central laboratory and support services to biopharmaceutical, medical device and contract research organizations; ConnectYourCare, a consumer-directed healthcare account administrator; and Bravo Wellness, a corporate wellness provider. MTS Health Investors MTS Health Investors is a private equity firm based in New York. The firm makes investments in a wide range of industries, with its healthcare investing targeting the provider services and life sciences/pharmaceutical industries. Nova Bright Capital Based in Chicago and founded in 2011, Nova Bright pursues a variety of investment opportunities in the middle market. Geoffrey serves as the chair of the firms private equity group. More information about Nova Bright is available at www.nova-bright.com. Read more about Ardan at Within healthcare, Riverside pursues investments in provider services and non-reimbursement healthcare industries, specifically within companies providing dermatology, dental and behavioral services, as well as providers of life sciences/pharmaceutical services. Webster Equity Partners (Waltham, Mass. In its current healthcare portfolio is Family Private Care, which specializes in providing private nursing care for Florida clients in homes, hospitals, assisted living facilities and nursing homes. Companies in its portfolio include Alignment Healthcare, a provider of healthcare management services to providers, health plans and hospitals, and eviCore healthcare, a specialty medical benefit management company that provides solutions to health plans and managed care organizations. Healthcare companies in its portfolio include IMS, a provider of outsourced hospitalist physicians programs to acute care facilities and community primary care physicians throughout Northern Ohio, and Resonetics, which provides laser micromachining manufacturing services for medical device and diagnostic companies. The firm seeks control equity investments in healthcare companies in the provider services industry and companies that live in the healthcare sector but do not have direct reimbursement risk, while also investing in other non-healthcare industries. Others, such as Solid Biosciences and Marinus Pharmaceuticals, are developing drugs for rare genetic disorders that affect the central nervous system. EDG Partners Founded in 2004 and with offices in Atlanta and Alexandria, Va., EDG makes a variety of investments in lower- and middle-market healthcare companies. www.ahpartners.com. Companies in its portfolio include Allied Digestive Health, a multi-specialty physician group; Cardiovascular Health Partners, a cardiovascular health services platform; DeliverHealth, a provider of professional and tech-enabled services designed to simplify EHR, revenue cycle and patient engagement complexities for health systems; and Clear Health Strategies, a tech-enabled payor services platform designed for managing non-standard medical claims. With 1,100 lawyers and 21 strategically located offices worldwide, McGuireWoods uses client-focused teams to serve public, private, government, and nonprofit clients from many industries, including automotive, energy resources, healthcare, technology, and transportation. Second quarter reports could bring questions on a reportedly forthcoming $40 billion takeover, GSKs new slimmed-down look and market uptake for expected blockbustersfrom Lilly and Bristol Myers. Geneva Glen seeks controlling or minority equity, and will consider a wide range of investments. Altaris is flexible in its investment sizes. More information about EDG is available at www.edgpartners.com. Leading Private Equity Firms That Invest in Healthcare (Part I), Healthcare & Life Sciences Private Equity Deal Tracker: Riverside Company Acquires Rockpointe, Healthcare & Life Sciences Private Equity Deal Tracker: Great Point Invests in Ephicacy, Healthcare & Life Sciences Private Equity Deal Tracker: Amulet Capital Sells OPEN Health, Subscribe to The Healthcare Investor by Email, Leading Private Equity Investors in Healthcare website, www.orix.com/capital-solution/healthcare/. Andrew Dunn www.appletreepartners.com, Founded in 2018, Ardan Equity is an alternative investment manager dedicated to the healthcare and life sciences software and data sectors. She sits on the firms Executive Committee and is a recognized leader in promoting the advancement of women in the private equity. Pharos Capital Group Founded in 1998, Pharos considers a variety of investments in lower- and middle-market companies primarily in healthcare and business services. Amber Walsh is the former Chairwoman of the firms Healthcare Department, one of the largest healthcare practices in the United States. Companies in its portfolio include NextCare, an independent urgent care provider with clinics across six states; Regency Healthcare Group, a provider of hospice and palliative care services; and West Dermatology, a physician practice management company that operates dermatology clinics in Nevada, Arizona and California. Healthcare and life sciences offer some undeniable opportunities that continue to fuel investor interest, and the fierce competition for many of the deals on the market in recent years has also caused investors to look deeper and more broadly at new niches. Amber Walsh is the former Chairwoman of the firms Healthcare Department, one of the largest healthcare practices in the United States. Companies in its portfolio include Virtus Pharmaceuticals, a specialty generics pharmaceutical company; Strata, a full-service anatomic pathology laboratory focused on the dermatology, urology, podiatry, oral pathology, gastroenterology and gynecology segments; and CORPAK MedSystems, a medical device company focused on enteral access technologies. McGuireWoods Healthcare Private Equity Team. Its latest fund is focused exclusively on the healthcare sector. Within healthcare, Pharos focuses on investing in companies that improve patient outcomes and/or lower the total cost of care. At McGuireWoods, we deliver quality work, personalized service, and exceptional value. Based in Los Angeles, the firm weighs a wide range of investments in healthcare services and several other industries. Bain's life sciences portfolio now includes over 30 companies. Based in Irvine, Calif., the firm targets companies with EBITDA from $2 million to $20 million across a variety of industries, including biotech, pharmaceutical and healthcare IT. Becker's Health IT + Digital Health + RCM, Patient Experience + Marketing Virtual Forum, Clinical Leadership + Pharmacy Virtual Event, Women's + Diversity Leadership Virtual Forum, Beckers Digital Health + Health IT Podcast, Becker's Ambulatory Surgery Centers Podcast, Becker's Cardiology + Heart Surgery Podcast, Current Issue - Becker's Clinical Leadership & Infection Control, Past Issues - Becker's Clinical Leadership & Infection Control, 150 top places to work in healthcare | 2022, 75 black healthcare leaders to know| 2022, 50 chief digital officer innovators to know | 2022, 250 healthcare revenue cycle management companies to know | 2022, 83 community hospital ceros to know | 2022, 50 community hospital cfos to know | 2022, ASC Annual Meeting: The Business and Operations of ASCs. Companies within EDGs portfolio include DiabetesAmerica, a health center and management program for individuals with diabetes; FirstCall Ambulance Service, a provider of scheduled, non-emergency ambulance and medical transport services; MMIS, a provider of cloud-based SaaS solutions for pharmaceutical, medical device and bio-pharmaceutical companies; and Peak Health Solutions, a health information management services company providing solutions in the areas of coding, compliance and CDI. Read more about Abry at Included in its portfolio is Jefferson Dental Clinics, a network of over 40 clinics in the Dallas/Fort Worth and Houston, Texas, metro areas, and Bright Now! Based in Chicago, the firm targets companies with EBITDA from $2 million to $20 million across healthcare services, specialty pharmacy, healthcare information technology, medical devices and life sciences. The Bain Capital square symbol is a trademark of Bain Capital, LP. Based in Chicago, the firm specializes in making control equity investments in healthcare companies that have $5 million to $50 million of revenue. Using data from Pitchbook, Healthcare Dive found private equity deals in the space more than doubled in the decade between 2008 and 2018, ultimately surpassing $100 billion in total value by that latter year. Privacy Policy. LLR Partners Founded in 1999 and based in Philadelphia, LLR pursues a wide range of growth investments in middle-market companies in healthcare services and several other industries. Based in New York, the firm invests in therapeutics and medical devices. More information about Riata is available at www.riatacapital.com. Log in to access your account information. Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses. Linden Capital Partners Founded in 2002 and based in Chicago, Linden seeks control equity in middle-market companies through more substantial investments from a dollars perspective. Cardurion Pharmaceuticals Announces Investment of up to $300 Million from Bain Capital. Within healthcare, the firm targets companies in the provider services and non-reimbursement healthcare industries. More information about LaSalle is available at www.lasallecapital.com. More information about High Street is available at www.highstreetcapital.com. By continuing to use our site, you acknowledge that you have read, that you understand, and that you accept our. LaSalle Capital Founded in 2004, LaSalle Capital is a Chicago-based firm with wide flexibility on investment size in the lower to middle market. More information about Geneva Glen is available at www.genevaglencapital.com. High Road Capital Partners Founded in 2007 and based in New York, High Road Capital Partners invests in healthcare and several other industries through lower middle-market transactions. www.amplebrightcapital.com, Founded in 1999, Apple Tree specializes in startup, early venture and growth capital investments. More information about Linden is available at www.lindenllc.com. Get the free daily newsletter read by industry experts. Our team draws upon individuals with senior experience in both the life science industry as well as public and private healthcare investing. These investors are primarily funds that focus largely on growth-stage, buyout and platform funding transactions. www.a-mcapital.com, Founded in 1986, American invests in middle market companies. Within healthcare, Sverica targets companies in the provider services and non-reimbursement healthcare industries, as well as hospitals and other major facilities. This column is the first in a multi-part series (part two is accessible here; part three is accessible here; part four is accessible here) we will be publishing in 2016 which highlights some of the more active private equity investors in the healthcare and life science space. The firm was founded in 2000, and pursues control equity investments in healthcare companies with strong growth prospects and profitable operating models. ORIX Healthcare Capital Founded in 1981, ORIX Healthcare is a business unit of Dallas-Based ORIX USA. Since the publication of the list below, we have seen more PE investors turn toward healthcare investments, new healthcare-focused funds form and healthcare PE deal activity continue at a staggering pace. The firm targets companies within the life sciences/pharmaceutical, provider services and non-reimbursement healthcare industries (meaning companies that live in the healthcare sector but do not have direct reimbursement risk, such as suppliers, management companies and healthIT). The company says a recent coverage decision by Medicare has forced it to end an observational trial of the Alzheimer's drug after enrolling just 29 participants. More recently, Bain became an investor of EQRxthrough a private investment alongside the biotech's merger with CM Life Sciences II, a so-called special purpose acquisition company.

• Louis Vuitton Chelsea Boots Men's
• Kobalt Tile Cutter Manual
• Croft And Barrow Pull On Capris
• Dr Colorchip Alternative
• Destin Inn And Suites Promo Code
• Lady Slipper Orchid For Sale Uk
• Cardigan Knitting Patterns
• Target Starbucks Mug Tiger
• Under Armour Pride 2021
• Green Trench Coat Women's
• It Cosmetics Love Your Skin With Confidence Skincare Set
• Vintage Exterior Door Hardware
• Jigsaw Puzzle Table Argos
• Febreze Air Freshener 4 Pack
• Clear Dining Chairs With Gold Legs
• Portable Pitcher Rinser
• Yoga Blocks Sports Direct
• Etnies Metal Mulisha Fader 2
• Upper Arm Slimming Sleeves